Abstract: A frequency multiplier in accordance with some embodiments of the inventive concept may include a pulse generator receiving a differential clock signal from a delay locked loop having a plurality of delay cells to generate a pulse signal for generation of a multiplication clock signal. The pulse generator comprises an intermediate pulse signal generation unit receiving the differential clock signal to generate intermediate pulse signals; and an overlap correction unit correcting an overlap between the intermediate pulse signals to generate correction pulse signals.

Abstract: An image diagnostic processing device includes peripheral region specifying means which specifies a peripheral region connecting to an abnormal candidate region included in an image representing the inside of a subject, and judging means which judges whether the abnormal candidate region is an anatomic abnormal region or not, based on a first feature quantity of the abnormal candidate region and a second feature quantity of the peripheral region.

Abstract: A computer-implemented method to generate a placement for a plurality of instances for an integrated circuit (IC) by utilizing a novel weighted-average (WA) wirelength model, which outperforms a well-known log-sum-exp wirelength model, to approximate the total wirelength. The placement is determined by performing an optimization process on an objective function which includes a wirelength function approximated by the WA wirelength model. The method can be extended to generate a placement for a plurality of instances for a three-dimensional (3D) integrated circuit (IC) which considers the sizes of through-silicon vias (TSVs) and the physical positions for TSV insertion. With the physical positions of TSVs determined during placement, 3D routing can easily be accomplished with better routed wirelength, TSV counts, and total silicon area.

Abstract: A bone plate manufacturing method includes an image acquisition step, an image reconstruction step, a comparison step, a data retrieval step, a model designing step and a bone plate manufacturing step. The image acquisition step acquires an original 3D craniofacial image. The image reconstruction step uses an image processing system to perform image reconstruction of the original 3D craniofacial image to obtain a reconstructed 3D craniofacial image, and the image processing system comprises a plurality of mechanical data. The comparison step compares the original 3D craniofacial image with the reconstructed 3D craniofacial image and defines the image difference therebetween as a defected portion. The data retrieval step retrieves a portion of the mechanical data and defines a mechanical compensation area on the reconstructed 3D craniofacial image. The model designing step designs a bone plate mold. The bone plate manufacturing step manufactures a bone plate.

Abstract: Monocyclic chlorine based inductively coupled plasma deep etching processes for the rapid micromachining of titanium substrates and titanium devices so produced are disclosed. The method parameters are adjustable to simultaneously vary etch rate, mask selectivity, and surface roughness and can be applied to titanium substrates having a wide variety of thicknesses to produce high aspect ratio features, smooth sidewalls, and smooth surfaces. The titanium microdevices so produced exhibit beneficially high fracture toughness, biocompatibility and are robust and able to withstand harsh environments making them useful in a wide variety of applications including microelectronics, micromechanical devices, MEMS, and biological devices that may be used in vivo.

Abstract: A system and method for determining at least one new treatment plan for at least one new patient, comprising: providing at least one representation of the at least one new patient's at least one organ at risk relative to at least one target; searching for at least one prior treatment plan for at least one prior patient with at least one similar representation; and reviewing the at least one prior treatment plan for the at least one prior patient in order to determine whether the at least one new treatment plan can be improved based on information in the at least one prior treatment plan.

Abstract: A capillary column (10) includes a tube structure having inner walls (14) and a sol-gel substrate (16) coated on a portion of inner walls (14) to form a stationary phase coating (18) on inner walls (14). The sol solution used to prepare the sol-gel substrate (16) has at least one baseline stabilizing reagent and at least one surface deactivation reagent resulting in the sol-gel substrate (16) having at least one baseline stabilizing reagent residual and at least one surface deactivating reagent residual. A method of making the sol-gel solution is by mixing suitable sol-gel precursors to form the solution, stabilizing the solution by adding at least one baseline stabilization reagent, deactivating the solution by adding at least one surface deactivation reagent to the solution, and reacting the solution in the presence of at least one catalyst.

Abstract: A 23 amino acid peptide, AtPep1, plays an important role as a signaling component of the innate immune system of Arabidopsis. The peptide precursor gene is transcribed in response to elicitors generated by pathogens, and AtPep1 is produced to amplify the signaling pathways. Seven paralogs of the AtproPep1 gene have been identified in the Arabidopsis genome, and orthologs have been identified in species of several agriculturally important families. AtPep1 and its paralogs and orthologs play important roles as endogenous signals to amplify innate immunity. The sequences of two AtPep1 receptors from Arabidopsis are also provided.

Abstract: Methods are provided for the treatment of subjects with cognitive or neuropsychiatric impairment induced by substance addiction and for increasing cognitive function in a subject with substance addiction. In some embodiments, the methods include administering to the subject a therapeutically effective amount of a major histocompatibility complex (MHC) molecule including covalently linked first, second, and third domains; wherein the first domain is an MHC class II ?1 domain and the second domain is an MHC class II ?1 domain; or wherein the first domain is an MHC class I ?1 domain and the second domain is an MHC class I ?2 domain; and wherein the third domain is covalently linked to the first domain and comprises an antigen of the central or peripheral nervous system.

Abstract: The present invention relates to systems and methods for dehumidifying air by establishing humidity gradients in one or more dehumidification units. Water vapor from relatively humid atmospheric air entering the dehumidification units is extracted by the dehumidification units without substantial condensation into low pressure water vapor vacuum volumes. The water vapor is extracted through water vapor permeable membranes of the dehumidification units into the low pressure water vapor vacuum volumes. The air exiting the dehumidification units is less humid than the air entering the dehumidification units. The low pressure water vapor extracted from the air is compressed to a slightly higher pressure, condensed, and removed from the system at ambient conditions. In addition, each of the dehumidification units may be associated with one or more evaporative cooling units through which the air will be directed, with the evaporative cooling units being upstream and/or downstream of the dehumidification units.

Abstract: The present invention provides a novel indoline derivative or a pharmacologically acceptable salt thereof or a solvate of the derivative or a salt thereof represented by the following formula (1) that has an excellent butyrylcholinesterase inhibitory activity. In the formula, R1 represents an alkyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, an arylalkyl group, a heteroarylalkyl group, a cycloalkylalkyl group, a heterocycloalkylalkyl group, a dihydrofurylalkyl group, an alkenyl group, a tetrahydronaphthyl group, or an indanyl group; R2 represents a hydrogen atom, an alkyl group, an arylalkyl group, a cycloalkylalkyl group, a heteroarylalkyl group, a heterocycloalkylalkyl group, an aryl group, or an acyl group; R3 each independently represents a hydrogen atom, an alkyl group, or a dialkylaminocarbonyl group; R4 each independently represents a hydrogen atom or an alkyl group; and R5 represents a hydrogen atom or an alkyl group.

Abstract: The invention provides triterpenoid compounds selected from betulinic acid, maslinic acid, oleanolic acid, esters thereof and mixtures of any two or more thereof for the treatment of sickle-cell anaemia.

Abstract: A shape memory polymer (SMP) intraocular lens may have a refractive index above 1.45, a Tg between 10° C. and 60° C., inclusive, de minimis or an absence of glistening, and substantially 100% transmissivity of light in the visible spectrum. The intraocular lens is then rolled at a temperature above Tg of the SMP material. The intraocular device is radially compressed within a die to a diameter of less than or equal to 1.8 mm while maintaining the temperature above Tg. The compressed intraocular lens device may be inserted through an incision less than 2 mm wide in a cornea or sclera or other anatomical structure. The lens can be inserted into the capsular bag, the ciliary sulcus, or other cavity through the incision. The SMP can substantially achieve refractive index values of greater than or equal to 1.45.

Abstract: Compositions and methods comprising bacteriophages are provided. In particular, the present invention includes novel and customized T4 bacteriophages uniquely designed for effective antigen and foreign particle presentation. The present invention also provides in vitro methods for the making of customized T4 bacteriophages. The compositions and methods of the present invention may be used for effective vaccine delivery systems.

Abstract: Following a diagnosis of ectopic pregnancy, at least one aromatase inhibitor, is administered to a patient, either alone or in combination with other aromatase inhibitors or therapeutic agents or as an adjuvant to conservative surgical treatment, such as laparoscopy, to prevent the establishment and/or continuation of the ectopic pregnancy. In certain preferred embodiments, the aromatase inhibitor is administered in conjunction with methotrexate.

Abstract: Preferred embodiments relate to compositions of inherently radiopaque, biocompatible, bioresorbable polymeric particles and methods of using them for embolizing a body lumen.

Abstract: A ceramic material having a high toughness can include carbon and a transition metal. The transition metal can have an elemental body centered cubic structure at room temperature. A substantial amount of the ceramic can be of a rhombohedral ? phase of the transition metal and carbon. These materials can have a high thermal shock resistance, high fracture toughness, and good high temperature performance. A particulate mixture of a carbon source and a transition metal source can be assembled (12) and reacted (14) under high pressure and high temperature. The transition metal source can include a transition metal of a metal which has an elemental BCC structure at room temperature. The particulate mixture carbon to transition metal ratio is chosen so as to achieve a zeta phase carbide and processing is affected in order to retain the zeta phase at a substantial weight percent of the material (i.e. greater than about 5 wt %).

Abstract: The present invention provides finite, addressable, and self-assembling nucleic acid tiling arrays, and methods for their use.

Abstract: The present invention relates to systems and methods for dehumidifying air by establishing humidity gradients in a plurality of dehumidification units, which are arranged in series and/or in parallel. Water vapor from air entering each stage of the plurality of dehumidification units is extracted by the dehumidification units without substantial condensation into low pressure water vapor chambers. For example, in one embodiment, the water vapor is extracted through water vapor permeable membranes of the dehumidification units into the low pressure water vapor chambers. As such, the air exiting each of the dehumidification units is less humid than the air entering the dehumidification units. The low pressure water vapor extracted from the air is subsequently compressed to a slightly higher pressure (i.e., just high enough to facilitate condensation), condensed, and removed from the system at ambient conditions.

Abstract: Provided is a microarray platform for the culture of cells atop combinatorial matrix mixtures; enabling the study of differentiation in response to a multitude of microenvironments in parallel.